The ROE as of December 2024 (TTM) for Checkpoint Therapeutics, Inc. (CKPT) is 359.97%

According to Checkpoint Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 359.97%. This represents a change of 286.04% compared to the average of 93.25% of the last 4 quarters.

Checkpoint Therapeutics, Inc. (CKPT) Historical ROE (quarterly & annually)

How has CKPT ROE performed in the past?

The mean historical ROE of Checkpoint Therapeutics, Inc. over the last ten years is -22.56%. The current 359.97% ROE has changed -1695.28% with respect to the historical average. Over the past ten years (40 quarters), CKPT's ROE was at its highest in in the September 2022 quarter at 787.12%. The ROE was at its lowest in in the June 2022 quarter at -188.93%.

Checkpoint Therapeutics, Inc. (CKPT) ROE by Quarter and Year

Discovering the peaks and valleys of Checkpoint Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Checkpoint Therapeutics, Inc. (CKPT) Average ROE

How has CKPT ROE performed in the past?

The current ROE of Checkpoint Therapeutics, Inc. (CKPT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Checkpoint Therapeutics, Inc. (CKPT) ROE vs. Peers

How is CKPT’s ROE compared to its peers?

Checkpoint Therapeutics, Inc.’s ROE is less than Mustang Bio, Inc. (429.53%), less than Reviva Pharmaceuticals Holdings, Inc. (1.15%), greater than Fortress Biotech, Inc. (-240.30%), greater than Kodiak Sciences Inc. (-84.52%), greater than Fortress Biotech, Inc. (-240.30%), greater than Avenue Therapeutics, Inc. (-473.61%), greater than Pieris Pharmaceuticals, Inc. (-76.24%), greater than Aileron Therapeutics, Inc. (-46.89%), greater than CytomX Therapeutics, Inc. (-41.34%), greater than Instil Bio, Inc. (-37.44%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than Spero Therapeutics, Inc. (3.36%), greater than Assembly Biosciences, Inc. (-121.46%), greater than Achilles Therapeutics plc (-54.57%), greater than Cue Biopharma, Inc. (-156.38%), greater than Medicenna Therapeutics Corp. (-159.88%), greater than XOMA Corporation (-33.68%), less than ZIVO Bioscience, Inc. (618.61%), greater than Lumos Pharma, Inc. (-233.03%),

Build a custom stock screener for Checkpoint Therapeutics, Inc. (CKPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Checkpoint Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Checkpoint Therapeutics, Inc. (CKPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Checkpoint Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.